Matches in Nanopublications for { ?s ?p "[EGFR activation is both a key molecular driver of disease progression and the target of a broad class of molecular agents designed to treat advanced cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- NP825017.RApZAekuMXjKMWQpeCrgrjJ6UJlZY-9wK4ni0dA1kyLFE130_assertion description "[EGFR activation is both a key molecular driver of disease progression and the target of a broad class of molecular agents designed to treat advanced cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP825017.RApZAekuMXjKMWQpeCrgrjJ6UJlZY-9wK4ni0dA1kyLFE130_provenance.
- NP986326.RAZfPzyTbGyOz0u9WGY4sI3HCC0xf7hipf4ypkTa36IEQ130_assertion description "[EGFR activation is both a key molecular driver of disease progression and the target of a broad class of molecular agents designed to treat advanced cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP986326.RAZfPzyTbGyOz0u9WGY4sI3HCC0xf7hipf4ypkTa36IEQ130_provenance.
- NP370221.RABqmyv9B1REddn9RKmTltOD2XnnhafLx5feXbQbtYKow130_assertion description "[EGFR activation is both a key molecular driver of disease progression and the target of a broad class of molecular agents designed to treat advanced cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP370221.RABqmyv9B1REddn9RKmTltOD2XnnhafLx5feXbQbtYKow130_provenance.